These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 27383536

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.
    Ge T, Yin M, Yang M, Liu T, Lou G.
    Cell Physiol Biochem; 2014; 34(6):2209-20. PubMed ID: 25562167
    [Abstract] [Full Text] [Related]

  • 23. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
    Tang W, Jiang Y, Mu X, Xu L, Cheng W, Wang X.
    Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
    [Abstract] [Full Text] [Related]

  • 24. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT, Gao JY, Wang HL, Wang Y, Wang H, Li PL.
    Genet Mol Res; 2015 Jul 31; 14(3):8766-77. PubMed ID: 26345808
    [Abstract] [Full Text] [Related]

  • 25. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
    Zhang L, Liu XL, Yuan Z, Cui J, Zhang H.
    Eur Rev Med Pharmacol Sci; 2019 Jun 31; 23(11):4663-4672. PubMed ID: 31210292
    [Abstract] [Full Text] [Related]

  • 26. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X, Chen S, Xiu YL, Sun KX, Zong ZH, Zhao Y.
    Mol Cancer; 2015 Feb 04; 14(1):31. PubMed ID: 25649143
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X, Li Y, Alvero A, Li J, Wu Q, Xiao Q, Peng Y, Hu Y, Li X, Yan W, Guo K, Zhou W, Wang Y, Liu J, Zhang Y, Mor G, Wen J, Yin G.
    Oncotarget; 2016 Dec 06; 7(49):80633-80654. PubMed ID: 27811362
    [Abstract] [Full Text] [Related]

  • 28. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.
    Li N, Zhao X, Wang L, Zhang S, Cui M, He J.
    Tumour Biol; 2016 Jun 06; 37(6):7767-76. PubMed ID: 26695144
    [Abstract] [Full Text] [Related]

  • 29. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B, Yang S, Liu T, Lou G.
    Mol Cancer; 2015 Mar 11; 14():57. PubMed ID: 25889927
    [Abstract] [Full Text] [Related]

  • 30. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
    Lin J, Zhang L, Huang H, Huang Y, Huang L, Wang J, Huang S, He L, Zhou Y, Jia W, Yun J, Luo R, Zheng M.
    Oncotarget; 2015 Sep 15; 6(27):23793-806. PubMed ID: 26204489
    [Abstract] [Full Text] [Related]

  • 31. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
    Zhang LY, Chen Y, Jia J, Zhu X, He Y, Wu LM.
    Cancer Biomark; 2019 Sep 15; 24(1):31-42. PubMed ID: 30614794
    [Abstract] [Full Text] [Related]

  • 32. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T, Liu T, Guo L, Chen Z, Lou G.
    Exp Cell Res; 2020 Nov 01; 396(1):112241. PubMed ID: 32835657
    [Abstract] [Full Text] [Related]

  • 33. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
    Lee M, Kim EJ, Jeon MJ.
    Oncotarget; 2016 Feb 23; 7(8):8726-42. PubMed ID: 26646586
    [Abstract] [Full Text] [Related]

  • 34. microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.
    Wang D, Lu G, Shao Y, Xu D.
    Biosci Rep; 2017 Apr 30; 37(2):. PubMed ID: 28188157
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
    Ibrahim FF, Jamal R, Syafruddin SE, Ab Mutalib NS, Saidin S, MdZin RR, Hossain Mollah MM, Mokhtar NM.
    J Ovarian Res; 2015 Aug 12; 8():56. PubMed ID: 26260454
    [Abstract] [Full Text] [Related]

  • 36. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W, Qiu L.
    PLoS One; 2014 Aug 12; 9(5):e96718. PubMed ID: 24816687
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
    Chen S, Chen X, Xiu YL, Sun KX, Zhao Y.
    Cancer Lett; 2015 Jun 28; 362(1):122-30. PubMed ID: 25819031
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene.
    Liu J, Dou Y, Sheng M.
    Biomed Pharmacother; 2016 Oct 28; 83():1286-1294. PubMed ID: 27567588
    [Abstract] [Full Text] [Related]

  • 39. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.
    Parikh A, Lee C, Joseph P, Marchini S, Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F, Mullokandov G, Fishman D, D'Incalci M, Rahaman J, Kalir T, Redline RW, Brown BD, Narla G, DiFeo A.
    Nat Commun; 2014 Oct 28; 5():2977. PubMed ID: 24394555
    [Abstract] [Full Text] [Related]

  • 40. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z.
    Carcinogenesis; 2013 Mar 28; 34(3):539-49. PubMed ID: 23188671
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.